{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:50:03Z","timestamp":1791669003698,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ero.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EULAR Rheumatology Open"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ero.2026.100255","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:26:48Z","timestamp":1791667608000},"page":"100255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sex-specific outcomes in methotrexate therapy among patients with psoriatic arthritis and psoriasis"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2405-4233","authenticated-orcid":false,"given":"Liana","family":"Barenbrug","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonul Hazal","family":"Koc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisol E","family":"Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmerik F A","family":"Leijten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander I","family":"van Leuven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene E","family":"van der Horst-Bruinsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juul M P A","family":"van den Reek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke M G J","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijn","family":"Vis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L M","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ero.2026.100255_bib0001","doi-asserted-by":"crossref","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ."},{"issue":"4","key":"10.1016\/j.ero.2026.100255_bib0002","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3899\/jrheum.220386","article-title":"Sex-specific differences in patients with psoriatic arthritis: a systematic review","volume":"50","author":"Coates","year":"2023","journal-title":"J Rheumatol."},{"issue":"4","key":"10.1016\/j.ero.2026.100255_bib0003","article-title":"Gender perspective in psoriasis: a scoping review and proposal of strategies for improved clinical practice by European dermatologists","volume":"9","author":"Gonzalez-Cantero","year":"2023","journal-title":"Int J Womens Dermatol."},{"issue":"12","key":"10.1016\/j.ero.2026.100255_bib0004","doi-asserted-by":"crossref","first-page":"e716","DOI":"10.1016\/S2665-9913(23)00264-3","article-title":"Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysis","volume":"5","author":"Eder","year":"2023","journal-title":"Lancet Rheumatol."},{"issue":"1","key":"10.1016\/j.ero.2026.100255_bib0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13075-021-02680-y","article-title":"Sex-specific differences and how to handle them in early psoriatic arthritis","volume":"24","author":"Passia","year":"2022","journal-title":"Arthritis Res Ther."},{"issue":"2","key":"10.1016\/j.ero.2026.100255_bib0006","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/rheumatology\/keab338","article-title":"Being overweight is associated with not reaching low disease activity in women but not men with psoriatic arthritis","volume":"61","author":"Mulder","year":"2022","journal-title":"Rheumatology (Oxford)."},{"issue":"4","key":"10.1016\/j.ero.2026.100255_bib0007","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s40257-017-0274-0","article-title":"Severity of psoriasis differs between men and women: a study of the clinical outcome measure Psoriasis Area and Severity Index (PASI) in 5438 Swedish Register Patients","volume":"18","author":"H\u00e4gg","year":"2017","journal-title":"Am J Clin Dermatol."},{"issue":"1","key":"10.1016\/j.ero.2026.100255_bib0008","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3711","article-title":"Effect of sex in systemic psoriasis therapy: differences in prescription, effectiveness and safety in the BIOBADADERM prospective cohort","volume":"101","author":"Hern\u00e1ndez-Fern\u00e1ndez","year":"2021","journal-title":"Acta Derm Venereol."},{"issue":"3","key":"10.1016\/j.ero.2026.100255_bib0009","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/24755303251327926","article-title":"Lower drug survival, less satisfaction and more adverse events in females using biologics for psoriasis: results of the Dutch BioCAPTURE registry","volume":"10","author":"Barenbrug","year":"2025","journal-title":"J Psoriasis Psoriatic Arthritis."},{"key":"10.1016\/j.ero.2026.100255_bib0010","article-title":"Biologic drug survival in psoriasis: a systematic review & comparative meta-analysis","volume":"7","author":"Mourad","year":"2020","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.ero.2026.100255_bib0011","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40257-021-00598-4","article-title":"Drug survival of IL-12\/23, IL-17 and IL-23 inhibitors for psoriasis treatment: a retrospective multi-country, multicentric cohort study","volume":"22","author":"Torres","year":"2021","journal-title":"Am J Clin Dermatol."},{"issue":"10","key":"10.1016\/j.ero.2026.100255_bib0012","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1093\/rheumatology\/kead089","article-title":"Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data","volume":"62","author":"Van Kuijk","year":"2023","journal-title":"Rheumatology (Oxford)."},{"issue":"4","key":"10.1016\/j.ero.2026.100255_bib0013","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/art.42758","article-title":"Sex differences in the effectiveness of first-line tumor necrosis factor inhibitors in psoriatic arthritis: results from the European spondyloarthritis research collaboration network","volume":"76","author":"Hellamand","year":"2024","journal-title":"Arthritis Rheumatol."},{"issue":"9","key":"10.1016\/j.ero.2026.100255_bib0014","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/rheumatology\/key140","article-title":"Gender differences in biologic treatment outcomes-a study of 1750 patients with psoriatic arthritis using Danish health care registers","volume":"57","author":"H\u00f8jgaard","year":"2018","journal-title":"Rheumatology (Oxford)."},{"issue":"2","key":"10.1016\/j.ero.2026.100255_bib0015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/bjd.15305","article-title":"Determinants for drug survival of methotrexate in patients with psoriasis, split according to different reasons for discontinuation: results of the prospective MTX-CAPTURE","volume":"177","author":"Otero","year":"2017","journal-title":"Br J Dermatol."},{"issue":"6","key":"10.1016\/j.ero.2026.100255_bib0016","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1089\/jwh.2019.8247","article-title":"Sex as a biological variable: a 5-year progress report and call to action","volume":"29","author":"Arnegard","year":"2020","journal-title":"J Womens Health (Larchmt)."},{"issue":"6","key":"10.1016\/j.ero.2026.100255_bib0017","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/ard-2024-225531","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update","volume":"83","author":"Gossec","year":"2024","journal-title":"Ann Rheum Dis."},{"issue":"8","key":"10.1016\/j.ero.2026.100255_bib0018","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41584-022-00798-0","article-title":"Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021","volume":"18","author":"Coates","year":"2022","journal-title":"Nat Rev Rheumatol."},{"issue":"11","key":"10.1016\/j.ero.2026.100255_bib0019","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/jdv.16915","article-title":"EuroGuiDerm guideline on the systemic treatment of Psoriasis vulgaris - part 1: treatment and monitoring recommendations","volume":"34","author":"Nast","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"2","key":"10.1016\/j.ero.2026.100255_bib0020","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/03009742.2020.1803398","article-title":"Lessons learned from clinical phenotypes in early psoriatic arthritis: the real-world Dutch south west Early Psoriatic ARthritis study","volume":"50","author":"Kasiem","year":"2021","journal-title":"Scand J Rheumatol."},{"issue":"4","key":"10.1016\/j.ero.2026.100255_bib0021","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/1756-185X.13271","article-title":"Gender differences in retention rate of tumor necrosis factor alpha inhibitor treatment in ankylosing spondylitis: a retrospective cohort study in daily practice","volume":"21","author":"Rusman","year":"2018","journal-title":"Int J Rheum Dis."},{"issue":"1","key":"10.1016\/j.ero.2026.100255_bib0022","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/acr.25048","article-title":"Female sex, age, and unfavorable response to tumor necrosis factor inhibitors in patients with axial spondyloarthritis: results of statistical and artificial intelligence-based data analyses of a national multicenter prospective registry","volume":"75","author":"Fern\u00e1ndez-Carballido","year":"2023","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"6","key":"10.1016\/j.ero.2026.100255_bib0023","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/03009742.2021.1967046","article-title":"Disease activity in women with ankylosing spondylitis remains higher under Tumour Necrosis Factor inhibitor treatment than in men: a five-year observational study","volume":"51","author":"Rusman","year":"2022","journal-title":"Scand J Rheumatol."},{"issue":"10","key":"10.1016\/j.ero.2026.100255_bib0024","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/jdv.15733","article-title":"Female patients are less satisfied with biological treatment for psoriasis and experience more side-effects than male patients: results from the prospective BioCAPTURE registry","volume":"33","author":"van der Schoot","year":"2019","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"4","key":"10.1016\/j.ero.2026.100255_bib0025","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/jdv.19730","article-title":"Sex differences in adverse events from systemic treatments for psoriasis: a decade of insights from the Swiss Psoriasis Registry (SDNTT)","volume":"38","author":"Verardi","year":"2024","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"5","key":"10.1016\/j.ero.2026.100255_bib0026","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1124\/mol.105.011080","article-title":"Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP\/ABCG2) in liver","volume":"67","author":"Merino","year":"2005","journal-title":"Mol Pharmacol."},{"issue":"3","key":"10.1016\/j.ero.2026.100255_bib0027","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","article-title":"Sex differences in pharmacokinetics and pharmacodynamics","volume":"48","author":"Soldin","year":"2009","journal-title":"Clin Pharmacokinet."},{"issue":"5","key":"10.1016\/j.ero.2026.100255_bib0028","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/ijd.16652","article-title":"Drug survival of methotrexate and predictor factors for discontinuation in psoriasis","volume":"62","author":"Caldarola","year":"2023","journal-title":"Int J Dermatol."},{"issue":"9","key":"10.1016\/j.ero.2026.100255_bib0029","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/ijd.15628","article-title":"Drug survival and predictor factors for discontinuation of methotrexate in psoriasis: a real-life multicenter study","volume":"60","author":"Ozkok Akbulut","year":"2021","journal-title":"Int J Dermatol."},{"issue":"6","key":"10.1016\/j.ero.2026.100255_bib0030","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ard.2025.02.023","article-title":"EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update","volume":"84","author":"R\u00fcegg","year":"2025","journal-title":"Ann Rheum Dis."}],"container-title":["EULAR Rheumatology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708126001540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708126001540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:26:51Z","timestamp":1791667611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050708126001540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S3050708126001540"],"URL":"https:\/\/doi.org\/10.1016\/j.ero.2026.100255","relation":{},"ISSN":["3050-7081"],"issn-type":[{"value":"3050-7081","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex-specific outcomes in methotrexate therapy among patients with psoriatic arthritis and psoriasis","name":"articletitle","label":"Article Title"},{"value":"EULAR Rheumatology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2026.100255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}],"article-number":"100255"}}